Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2012
06/28/2012US20120165328 Inhibitors of b lymphocyte kinase
06/28/2012US20120165326 Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro benzothiazoles and 5-fluoro benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
06/28/2012US20120165322 Rho kinase inhibitors
06/28/2012US20120165319 Inhibitors of interleukin-1 beta converting enzyme
06/28/2012US20120165314 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
06/28/2012US20120165313 Pyrimidine compounds, compositions and methods of use
06/28/2012US20120165310 Ether derivatives of bicyclic heteroaryls
06/28/2012US20120165305 Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
06/28/2012US20120165304 6,7,8,9-Tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
06/28/2012US20120165303 Triazolyl phenyl benzenesulfonamides
06/28/2012US20120165298 Sulfonamide compounds
06/28/2012US20120165196 Hydrate of sulfonylurea compound, process for producing the same and suspension formulation containing the same
06/28/2012US20120161117 P-type materials and organic electronic devices
06/28/2012DE102011089353A1 Verfahren zur Herstellung von Tetrahydrotetraazapentacenen und Derivaten Process for the preparation of derivatives and Tetrahydrotetraazapentacenen
06/28/2012DE102011089350A1 Tetrahydrotetraacene in Dünnschichttransistoren Tetrahydrotetraacene in thin-film transistors
06/28/2012DE102010056443A1 New chlorin derivative useful as photosensitizer in photodynamic tumor therapy
06/28/2012CA2822400A1 Novel cyclic amine compound and process for producing polyurethane resin by using it
06/28/2012CA2821546A1 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives
06/28/2012CA2820448A1 2-amino-4-arylthiazole compounds as trpa1 antagonists
06/28/2012CA2819825A1 Compositions and methods for modulating fxr
06/28/2012CA2819175A1 5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (bace)
06/28/2012CA2818623A1 Novel antifungal 5,6-dihydro-4h-pyrrolo[1,2-.alpha.][1,4]- benzodiazepines and 6h-pyrrolo[1,2-.alpha.][1,4]benzodiazepines substituted with bicyclic benzene derivatives
06/27/2012EP2468717A1 Heterocyclic Amide Compounds Useful as Kinase Inhibitors
06/27/2012EP2468287A1 Macrocyclic hepatitis c serine protease inhibitors
06/27/2012EP2468286A1 Macrocyclic hepatitis C serine protease inhibitors
06/27/2012EP2468285A1 Macrocyclic hepatitis C serine protease inhibitors
06/27/2012EP2467141A1 Heterocyclic compounds and uses thereof
06/27/2012EP2084130B1 Process for preparing 5-alkyl-7h-pyrrolo[2,3-d]pyrimidine-2-ols
06/27/2012EP1919921B1 Bicyclic heterocycles as hiv integrase inhibitors
06/27/2012EP1719762B1 Novel pyridine derivative and pyrimidine derivative (1)
06/27/2012EP1587480B1 Polyhydroxylated pyrrolizidine
06/27/2012EP1549313B1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
06/27/2012EP1127265B1 Method for non-invasive imaging oxygen distribution in multi-dimensions and apparatus therefor
06/27/2012CN1995041B Pyridazineindole derivative and its use
06/27/2012CN1882587B Use of tricyclic compounds as glycine transport inhibitors
06/27/2012CN102516251A Medicines for targeted diagnosis and photosensitive therapy for cancer and application for same
06/27/2012CN102516250A Synthesizing method of compound zaleplon
06/27/2012CN102516249A Anticoagulant diamine derivative
06/27/2012CN102516248A n-type organic semiconductor material containing oblique line type naphthalimide unit
06/27/2012CN102516155A 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols
06/27/2012CN102516146A Quaternary nitrogen varied volution derivate with 5 position as nitrogen and preparation method and use thereof
06/27/2012CN102513154A Pyrrolidine derived imide catalyst as well as preparation method and application thereof
06/27/2012CN101715453B Heterocyclic compounds and their uses
06/27/2012CN101679446B 3,3-spiroindolinone derivatives
06/27/2012CN101679416B Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3, 4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceu
06/27/2012CN101679241B Prolinamide derivatives as NK3 antagonists
06/27/2012CN101671339B Citric acid alidenafil crystal form B and preparation method and usage thereof
06/27/2012CN101663303B Heteroaromatic compounds, the preparation method and the use thereof
06/27/2012CN101573362B Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
06/27/2012CN101501002B Non-nucleoside reverse transcriptase inhibitors
06/27/2012CN101448835B 6,7,8, 9 -tetrahydro- 5h- pyrimido [4, 5-d] azepin-4-yl] -amine derivatives as modulators of trpvl for the treatment of pain
06/27/2012CN101291934B Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
06/27/2012CN101103000B Carbazole, carboline, and indole derivatives useful in the inhibition of VEGF production
06/26/2012US8207353 Poly(ethylene glycol) containing chemically disparate endgroups
06/26/2012US8207340 Imidazopyridinyl benzamide mitotic kinesin inhibitors
06/26/2012US8207334 Bicyclic pyrimidinones and uses thereof
06/26/2012US8207330 Two-photon absorption material and application thereof
06/26/2012US8207329 Synthesis of chlorins and phorbines with enhanced red spectral features
06/26/2012US8207212 Methods and devices for epithelial protection during photodynamic therapy
06/26/2012US8207211 Photosensitizers for targeted photodynamic therapy
06/26/2012US8207183 Inhibitors of IAP
06/26/2012US8207180 Tricyclic indoles and (4,5-dihydro) indoles
06/26/2012US8207178 Fused pyrimidines as reverse transcriptase inhibitors
06/26/2012US8207177 Inhibitors of E1 activating enzymes
06/26/2012US8207173 Benzimidazoles and analogs thereof as antivirals
06/26/2012US8207162 Chiral fused [1,2]imidazo[4,5-c] ring compounds
06/26/2012US8207161 Tetrahydro-imidazo[1,5-α]pyrazine derivatives, preparation process and medicinal use thereof
06/26/2012US8207158 5HT2c receptor modulators
06/26/2012US8207154 Palladium 31-oxo-15- methoxycarbonylmethyl- Rhodobacteriochlorin-131-(2-N3- trimethylammoniumethyl)amide acetate (salt); bacteriochlorophylls free of carbamate group; as photosensitizer for thermodynamic therapy and diagnosis; cancer, age related macular degeneration; killing viruses and bacteria
06/26/2012US8207153 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
06/26/2012US8206497 Polyphenylated phthalocyanines with near-infrared absorption
06/26/2012US8206496 Mixed phthalocyanine and naphthalocyanine dyes for near-infrared applications
06/26/2012CA2566609C Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
06/23/2012CA2762460A1 Tetrahydrotetraazaapentacenes in thin-film transistors
06/23/2012CA2762455A1 Process for preparing tetrahydrotetraazapentacenes and derivatives
06/21/2012WO2012083181A1 Alpha helix mimetics and methods for using
06/21/2012WO2012082997A1 Tricyclic pi3k inhibitor compounds and methods of use
06/21/2012WO2012082213A2 Conductive open frameworks
06/21/2012WO2012080990A1 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
06/21/2012WO2012080735A1 Ask1 inhibiting pyrrolopyrimidine derivatives
06/21/2012WO2012080457A1 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
06/21/2012WO2012080456A1 Bicyclic ring system substituted amide functionalised phenols as medicaments
06/21/2012WO2012080451A1 Imidazopyridines as respiratory syncytial virus antiviral agents
06/21/2012WO2012080237A1 Substituted pyrimido[1,2-b]indazoles and their use as modulators of the pi3k/akt pathway
06/21/2012WO2012080236A1 6-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
06/21/2012WO2012080234A1 Substituted 6-imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
06/21/2012WO2012080232A1 2-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
06/21/2012WO2012080230A1 6 substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
06/21/2012WO2012080229A1 Imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment hyperproliferative disorders
06/21/2012WO2012080228A1 6-thio-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
06/21/2012US20120157689 Substituted indolocarbazoles
06/21/2012US20120157658 Methods, compositions, and apparatuses for forming macrocyclic compounds
06/21/2012US20120157479 3-hydroxypyrrolidine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase
06/21/2012US20120157468 Plk inhibitor salts
06/21/2012US20120157460 Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
06/21/2012US20120157458 Imidazotriazinone compounds
06/21/2012US20120157453 Raf inhibitor compounds and methods of use thereof
06/21/2012US20120157451 Raf inhibitor compounds and methods of use thereof
06/21/2012US20120157443 Bruton's tyrosine kinase inhibitors
06/21/2012US20120157442 Heteroaryl btk inhibitors
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 573